What is the current valuation of the Neurorehabilitation Devices Market?

As of 2024, the Neurorehabilitation Devices Market was valued at 0.8732 USD Billion. Read More

What is the projected market size for the Neurorehabilitation Devices Market by 2035?

The market is expected to reach a valuation of 2.015 USD Billion by 2035. Read More

What is the expected CAGR for the Neurorehabilitation Devices Market during the forecast period?

The anticipated CAGR for the Neurorehabilitation Devices Market from 2025 to 2035 is 7.9%. Read More

Which segments are included in the Neurorehabilitation Devices Market?

The market segments include Neuro-Robotic Devices, Wearable Medical Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces. Read More

Who are the leading players in the Neurorehabilitation Devices Market?

Prominent players include ReWalk Robotics, Ekso Bionics, Cyberdyne, Bionik Laboratories, and Medtronic. Read More

What is the market size for Neuro-Robotic Devices in 2024?

In 2024, the market size for Neuro-Robotic Devices was approximately 0.3005 USD Billion. Read More

How does the market size for Wearable Medical Devices compare to other segments?

Wearable Medical Devices had a market size of 0.25 USD Billion in 2024, indicating a growing interest in this segment. Read More

What is the expected market size for rehabilitation centers by 2035?

By 2035, the market size for rehabilitation centers is projected to reach 0.8 USD Billion. Read More

What is the significance of home care in the Neurorehabilitation Devices Market?

Home care is expected to grow, with a projected market size of 0.415 USD Billion by 2035. Read More

Neurorehabilitation Devices Market

Q: What are the key applications of Neurorehabilitation Devices?

Key applications encompass Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Cerebral Palsy, and Schizophrenia. Read More

ID: MRFR/MED/1642-CR

115 Pages

Vikita Thakur

Last Updated: June 05, 2026

Neurorehabilitation Devices Market Research Report Information By Type (Neuro-Robotic Devices, Wearable Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), By Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Cerebral Palsy, and Schizophrenia), By End-User (Rehabilitation Centers, Hospitals & Clinics, and Home Care) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Prevalence of Neurological Disorders | |
  2. 3.1.2 Regulatory Clearances for Brain-Computer Interfaces | |
  3. 3.1.3 Advances in Robotic-Assisted Neuro Therapy | |
  4. 3.1.4 Telerehabilitation and Remote Monitoring Expansion | |
  5. 3.1.5 Aging Population Demographics | |
  6. 3.1.6 Government Neuroscience Funding Programs | |
  7. 3.1.7 Insurance and Reimbursement Code Expansion |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Device Cost and Limited Reimbursement in LMICs | |
  2. 3.2.2 Shortage of Trained Neurorehabilitation Specialists | |
  3. 3.2.3 Regulatory Fragmentation Across Jurisdictions | |
  4. 3.2.4 Limited Clinical Evidence for Newer Modalities | |
  5. 3.2.5 Data Privacy and Cybersecurity Concerns |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 AI-Powered Personalized Rehabilitation Protocols | |
  2. 3.3.2 Home-Use Neurorehabilitation Devices | |
  3. 3.3.3 Emerging Market Infrastructure Build-Out | |
  4. 3.3.4 Data Monetization and Outcome-Based Payment Models | |
  5. 3.3.5 Telerehabilitation in Rural and Underserved Regions |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Neurorehabilitation Devices Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Million) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product Type | |
  1. 5.1.1 Neuro-Robotic Devices | |
  2. 5.1.2 Wearable Devices | |
  3. 5.1.3 Non-Invasive Stimulators | |
  4. 5.1.4 Brain-Computer Interfaces |
2. 5.2 By End User | |
  1. 5.2.1 Hospitals/Clinics | |
  2. 5.2.2 Cognitive Care Centers | |
  3. 5.2.3 Others (Home Care, Research Institutions)
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Hocoma (DIH Group) | |
  2. 7.3.2 Ekso Bionics | |
  3. 7.3.3 Bionik Laboratories | |
  4. 7.3.4 Medtronic | |
  5. 7.3.5 Abbott Laboratories | |
  6. 7.3.6 BrainCo | |
  7. 7.3.7 Nuvectra Corporation | |
  8. 7.3.8 MindMaze | |
  9. 7.3.9 Neurolutions | |
  10. 7.3.10 Nexstim
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI and Closed-Loop Adaptive Therapy |
2. 8.2 Platform Economics and Device-as-a-Service |
3. 8.3 Neural Plasticity Research Breakthroughs |
4. 8.4 Global Health Equity and Frugal Innovation
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Neurorehabilitation Devices Market Size & Forecast, by Revenue (USD Million), 2021–2035 |
TABLE 2 Global Neurorehabilitation Devices Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis — Neurorehabilitation Devices Market, 2026–2035 |
TABLE 4 Restraints Impact Analysis — Neurorehabilitation Devices Market, 2026–2035 |
TABLE 5 Regional Market Share Summary — Neurorehabilitation Devices Market, 2025 |
TABLE 6 North America Neurorehabilitation Devices Market, by Country, 2025 |
TABLE 7 Europe Neurorehabilitation Devices Market, by Country, 2025 |
TABLE 8 Asia-Pacific Neurorehabilitation Devices Market, by Country, 2025 |
TABLE 9 South America Neurorehabilitation Devices Market, by Country, 2025 |
TABLE 10 Middle East & Africa Neurorehabilitation Devices Market, by Country, 2025 |
TABLE 11 Neurorehabilitation Devices Market Size, by Product Type, 2025 |
TABLE 12 Neurorehabilitation Devices Market Size, by End User, 2025 |
TABLE 13 Competitive Benchmarking Matrix — Neurorehabilitation Devices Market, 2025 |
TABLE 14 Recent Developments & Strategic Announcements, 2024–2025 |
TABLE 15 Report Scope & Methodology Summary |
TABLE 16 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Neurorehabilitation Devices Market Dynamics — Drivers, Restraints, Opportunities |
FIGURE 2 Industry Value Chain Analysis — Neurorehabilitation Devices Market |
FIGURE 3 Porter's Five Forces Analysis — Neurorehabilitation Devices Market |
FIGURE 4 Global Neurorehabilitation Devices Market Size Trend (USD Million), 2021–2035 |
FIGURE 5 Neurorehabilitation Devices Market Share, by Product Type, 2025 |
FIGURE 6 Neurorehabilitation Devices Market Share, by End User, 2025 |
FIGURE 7 Neurorehabilitation Devices Market Share, by Region, 2025 |
FIGURE 8 North America Neurorehabilitation Devices Market Share, by Country, 2025 |
FIGURE 9 Europe Neurorehabilitation Devices Market Share, by Country, 2025 |
FIGURE 10 Asia-Pacific Neurorehabilitation Devices Market Share, by Country, 2025 |
FIGURE 11 South America Neurorehabilitation Devices Market Share, by Country, 2025 |
FIGURE 12 Middle East & Africa Neurorehabilitation Devices Market Share, by Country, 2025 |
FIGURE 13 Competitive Landscape — Market Concentration and Share Analysis, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product Type	Neuro-Robotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interfaces	Neuro-Robotic Devices (~35% share)	Brain-Computer Interfaces (CAGR ~18.2%)
By End User	Hospitals/Clinics, Cognitive Care Centers, Others	Hospitals/Clinics (~52% share)	Cognitive Care Centers (CAGR ~16.1%)
By Geography	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America (~38% share)	Asia-Pacific (CAGR ~16.5%)

Market Segmentation Overview

By Product Type

Sub-Segment	Key Trend
Neuro-Robotic Devices	Transition from research-only to community hospital deployment; AI-enhanced motion control
Wearable Devices	Miniaturization enabling home-use applications; integration with telerehabilitation platforms
Non-Invasive Stimulators	Expanding outpatient TMS and tDCS adoption; growing insurance coverage for depression and motor recovery
Brain-Computer Interfaces	FDA and CE regulatory breakthroughs; hybrid BCI-gamification therapy platforms

Neuro-robotic devices remain the largest product type by revenue, anchored to hospital capital expenditure cycles and strong clinical evidence for motor recovery outcomes. Brain-computer interfaces are emerging as the fastest-growing category as regulatory pathways mature and clinical trial data demonstrates efficacy in bypassing damaged neural circuits for stroke rehabilitation.

By End User

Sub-Segment	Key Trend
Hospitals/Clinics	Integrated neurorehabilitation units with robotic and digital therapy suites
Cognitive Care Centers	Purpose-built facilities for dementia and TBI, expanding across North America and Europe
Others (Home Care, Research)	Direct-to-consumer wearable approvals; growing academic research procurement

Hospitals and clinics continue to dominate end-user demand given the capital-intensive nature of neuro-robotic systems and the requirement for specialist oversight. Cognitive care centers represent the fastest-growing channel as healthcare systems establish dedicated facilities equipped with specialized cognitive rehabilitation and neural plasticity therapy technologies.

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”